The U.K. is locked in drug-pricing negotiations with the Trump administration and pharmaceutical firms about how much the National Health Service pays for their products through the so-called Voluntary Scheme for Pricing, Access and Growth…
US pharma to abandon UK unless NHS pays more, says Trump’s ambassador – POLITICO
